Physician profile
Alan Phillip Mullins
NPI 1790784676
$8,669.50
in general payments reported to CMS, 2019-2025
34 companies · $1,797 in 2025
The $1,797 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,901 · 2020: $710 · 2021: $247 · 2022: $394 · 2023: $977 · 2024: $1,643 · 2025: $1,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,971 · Education: $1,568 · Travel and Lodging: $869 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.85 |
| Education | $1,568.49 |
| Travel and Lodging | $869.18 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,288.19 | 2019-2025 | Da Vinci Surgical System |
| Allergan, INC. | $969.26 | 2019-2022 | |
| Davol INC. | $342.94 | 2020-2023 | Phasix Mesh |
| Ethicon US, LLC | $321.57 | 2019-2024 | Stratafix, Evarrest, Vistaseal |
| Takeda Pharmaceuticals U.S.A., INC. | $226.11 | 2020-2025 | Gattex |
| Boston Scientific Corporation | $168.39 | 2020-2024 | Varithena Administration Pack, Eluvia |
| Tela Bio, INC. | $152.38 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Astrazeneca Pharmaceuticals LP | $131.95 | 2024-2025 | Imfinzi, Tagrisso |
| Shire North American Group INC | $116.28 | 2019 | |
| Medtronic, INC. | $107.55 | 2022-2023 | Situate, Gi Genius |
| Kerecis Limited | $95.25 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Covidien LP | $87.50 | 2019 | |
| Abbvie INC. | $75.91 | 2022-2025 | |
| Becton, Dickinson and Company | $69.46 | 2022 | |
| Merck Sharp & Dohme LLC | $57.44 | 2022-2025 | Keytruda |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $44.44 | 2024-2025 | Activ.A.C., Prevena Restor Arthroform, Promogran Prisma |
| Melinta Therapeutics, LLC | $42.99 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $37.65 | 2025 | |
| W. L. Gore & Associates, INC. | $37.25 | 2020-2023 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Smith+Nephew, INC. | $36.61 | 2024 | Renasys Touch |
| Molli Surgical (US) INC | $35.66 | 2022 | |
| Pfizer INC. | $27.91 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $26.20 | 2025 | Libtayo |
| Aroa Biosurgery Incorporated | $21.32 | 2024 | |
| Csl Behring | $20.26 | 2022 | |
| Ekos Corporation | $17.77 | 2019 | |
| Olympus America INC. | $15.74 | 2023 | 4k Cable 8.5m |
| Tetraphase Pharmaceuticals, INC. | $15.26 | 2019 | |
| Organogenesis INC. | $15.10 | 2023 | Puraply |
| Integra Lifesciences Corporation | $15.07 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.06 | 2023 | Seglentis |
| Bard Peripheral Vascular, INC. | $13.40 | 2023 | Venclose Maven Catheter |
| Ambu INC. | $12.30 | 2022 | |
| Polynovo North America LLC | $9.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Mullins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.